Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal ...

The Gordian Knot that is the legal case surrounding Purdue Pharma's role in the opioid crisis got an extra twist Monday when creditors asked a bankruptcy court for permission to sue the company's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Detailed price information for Medipharm Labs Corp (MEDIF) from The Globe and Mail including charting and trades.

Opioid-Pusher Pidduck, Chairman Chris Taves and the Current MediPharm Board Have Presided Over $1 Billion in Shareholder Value Destruction while funneling $5,587,059 of the Shareholders’ Money ...

Eli Lilly's (NYSE: LLY) share price soared during the first Trump ... it's a much different story so far in Trump's second term. The big pharma stock has taken investors on a roller coaster ...

Also Read: UroGen Pharma Touts Four-Year Response With Urothelial ... would warrant a reassessment of their current rating on the stock. Selvaraju notes that UroGen concluded the first quarter ...

The average 12-month price target for Pfizer reflects an upside potential of 28%. Why is there a significant level of optimism on Wall Street about this beaten-down pharma stock? For one thing ...

The decision can be attributed to increasing competitive pressure and recent market challenges that have led to a decline in the company’s stock price since mid-2024. Also, the Novo Nordisk ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo ...

(Reuters) - A former McKinsey & Co partner was sentenced on Thursday to six months in prison for obstructing justice by destroying records related to advice the consulting firm gave Purdue Pharma ...